News AI-powered study backs anticoagulants for heart failure pati... A new study has found that blood thinning drugs improve outcomes for all heart failure patients, regardless of whether they already have atrial fibrillation (AF).
Views & Analysis Real-world or real evidence? There was a time when the distinction between data from clinical trials and data from any other source was clear.
Views & Analysis Demonstrating the value of RWE A new cross-industry effort hopes to research the benefits of RWE and promote acceptance of alternatives to traditional trials.
Views & Analysis Is the NHS ready to use real-world evidence to treat cancer? Is NHS ready to use real-world data to find new therapies and ways to bring drugs to patients?
Views & Analysis Behind the buzz of real-world data and real-world evidence Putting the who, where and why of real-world studies into context.
News FDA fast-tracks Sanofi's gene therapy for eye disease GA Sanofi has been granted a speedy review from the FDA for a gene therapy for geographic atrophy, a major cause of blindness.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face